parkinsons disease Gene Set

Dataset KEGG Pathways
Category structural or functional annotations
Type pathway
Description A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75)|A neurodegenerative disease that results_from degeneration of the central nervous system that often impairs the sufferer's motor skills, speech, and other functions. (Experimental Factor Ontology, EFO_0002508)
Similar Terms
Downloads & Tools

Genes

17 proteins participating in the parkinsons disease pathway from the KEGG Pathways dataset.

Symbol Name
CYP2D6 cytochrome P450, family 2, subfamily D, polypeptide 6
GPR37 G protein-coupled receptor 37 (endothelin receptor type B-like)
PARK2 parkin RBR E3 ubiquitin protein ligase
PARK7 parkinson protein 7
PINK1 PTEN induced putative kinase 1
SEPT5 septin 5
SNCA synuclein, alpha (non A4 component of amyloid precursor)
SNCAIP synuclein, alpha interacting protein
STX1A syntaxin 1A (brain)
TH tyrosine hydroxylase
UBA1 ubiquitin-like modifier activating enzyme 1
UBB ubiquitin B
UBE2G2 ubiquitin-conjugating enzyme E2G 2
UBE2J2 ubiquitin-conjugating enzyme E2, J2
UBE2L3 ubiquitin-conjugating enzyme E2L 3
UBE2L6 ubiquitin-conjugating enzyme E2L 6
UCHL1 ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase)